Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Newsummit Launches $100 Million Fund for US Medical Device Makers

publication date: Sep 28, 2011
Newsummit Pharmaceutical Group teamed up with the Cleveland Bio Fund in a $100 million effort to help US biomedical device companies to commercialize their products in China. The funds were raised in China, where Newsummit is located. Cleveland Bio Fund will identify Cleveland-area medical device companies with US-approved products. These companies will be small-to-medium sized entities that have not been able to bring their products to China. Once all the candidates in the Cleveland area have been examined, the fund will widen its search to include companies from elsewhere in the US.

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here